Anika Therapeutics Inc (ANIK)
25.95
+0.11
(+0.43%)
USD |
NASDAQ |
Apr 22, 16:00
25.99
+0.04
(+0.15%)
After-Hours: 20:00
Anika Therapeutics Enterprise Value: 312.49M for April 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 22, 2024 | 312.49M |
April 19, 2024 | 310.85M |
April 18, 2024 | 304.77M |
April 17, 2024 | 308.63M |
April 16, 2024 | 305.95M |
April 15, 2024 | 302.98M |
April 12, 2024 | 298.38M |
April 11, 2024 | 307.44M |
April 10, 2024 | 311.15M |
April 09, 2024 | 311.60M |
April 08, 2024 | 306.70M |
April 05, 2024 | 307.59M |
April 04, 2024 | 313.38M |
April 03, 2024 | 317.39M |
April 02, 2024 | 310.71M |
April 01, 2024 | 308.78M |
March 28, 2024 | 304.32M |
March 27, 2024 | 306.40M |
March 26, 2024 | 303.73M |
March 25, 2024 | 299.72M |
March 22, 2024 | 305.21M |
March 21, 2024 | 304.17M |
March 20, 2024 | 307.14M |
March 19, 2024 | 303.88M |
March 18, 2024 | 302.39M |
Date | Value |
---|---|
March 15, 2024 | 304.91M |
March 14, 2024 | 291.55M |
March 13, 2024 | 304.32M |
March 12, 2024 | 310.11M |
March 11, 2024 | 310.11M |
March 08, 2024 | 304.62M |
March 07, 2024 | 303.58M |
March 06, 2024 | 313.68M |
March 05, 2024 | 314.45M |
March 04, 2024 | 308.44M |
March 01, 2024 | 295.69M |
February 29, 2024 | 283.08M |
February 28, 2024 | 290.26M |
February 27, 2024 | 297.44M |
February 26, 2024 | 299.50M |
February 23, 2024 | 306.68M |
February 22, 2024 | 291.14M |
February 21, 2024 | 288.06M |
February 20, 2024 | 282.64M |
February 16, 2024 | 282.05M |
February 15, 2024 | 287.62M |
February 14, 2024 | 272.96M |
February 13, 2024 | 268.86M |
February 12, 2024 | 279.12M |
February 09, 2024 | 279.41M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
132.14M
Minimum
Mar 18 2020
873.60M
Maximum
Oct 25 2019
386.77M
Average
377.29M
Median
Feb 28 2023
Enterprise Value Benchmarks
The Cooper Companies Inc | 20.53B |
Staar Surgical Co | 2.056B |
OrthoPediatrics Corp | 646.67M |
NexGel Inc | 12.18M |
Innovative Eyewear Inc | -1.207M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -63.00M |
Revenue (Quarterly) | 42.97M |
Total Expenses (Quarterly) | 44.56M |
EPS Diluted (Quarterly) | -4.30 |
Gross Profit Margin (Quarterly) | 61.27% |
Profit Margin (Quarterly) | -146.6% |
Earnings Yield | -21.77% |
Normalized Earnings Yield | -21.77 |